Stryker (SYK) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $293.23, +4.12% vs the prior close of $281.62.
- Volume 3.12M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SYK jumps 4.1% to $293.23, a 1-month high. Closed at $293.23, +4.12% vs the prior close of $281.62. Day range $286.55–$293.99, opened at $287.00.
SYK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SYK jumps 4.1% to $293.23, a 1-month high
- Closed at $293.23, +4.12% vs the prior close of $281.62. Day range $286.55–$293.99, opened at $287.00.
- Volume was 3.12M shares, 1.2x its 50-day average of 2.60M.
- Price is -2.5% vs its 50-day average ($300.80) and -10.3% vs its 200-day average ($326.94).
- 52-week range $267.00–$392.55; today's close sits at 21% of that range, 25.3% below the 52-week high.
Oct 14, 2026 — SYK dips 0.3% to $281.62
- Closed at $281.62, -0.33% vs the prior close of $282.55. Day range $278.58–$285.66, opened at $285.66.
- Volume was 2.23M shares, 0.8x its 50-day average of 2.62M.
- Price is -6.6% vs its 50-day average ($301.68) and -13.9% vs its 200-day average ($327.24).
- 52-week range $267.00–$392.55; today's close sits at 12% of that range, 28.3% below the 52-week high.
Oct 13, 2026 — SYK ends flat (-0.0%) to $282.55
- Closed at $282.55, -0.02% vs the prior close of $282.60. Day range $278.62–$287.45, opened at $284.23.
- Volume was 2.07M shares, 0.8x its 50-day average of 2.63M.
- Price is -6.7% vs its 50-day average ($302.76) and -13.8% vs its 200-day average ($327.60).
- 52-week range $267.00–$392.55; today's close sits at 12% of that range, 28.0% below the 52-week high.
Oct 12, 2026 — SYK rises 1.9% to $282.60, 3 up days in a row
- Closed at $282.60, +1.90% vs the prior close of $277.33. Day range $274.50–$283.65, opened at $277.30.
- Volume was 1.81M shares, 0.7x its 50-day average of 2.69M.
- Price is -7.0% vs its 50-day average ($303.94) and -13.8% vs its 200-day average ($327.96).
- 52-week range $267.00–$392.55; today's close sits at 12% of that range, 28.0% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — SYK ends flat (+0.1%) to $277.33
- Closed at $277.33, +0.13% vs the prior close of $276.97. Day range $276.53–$281.58, opened at $277.01.
- Volume was 1.48M shares, 0.5x its 50-day average of 2.71M — lighter than usual.
- Price is -9.0% vs its 50-day average ($304.80) and -15.5% vs its 200-day average ($328.32).
- 52-week range $267.00–$392.55; today's close sits at 8% of that range, 29.4% below the 52-week high.
Oct 8, 2026 — SYK rises 0.6% to $276.97
- Closed at $276.97, +0.57% vs the prior close of $275.40. Day range $271.67–$277.97, opened at $275.72.
- Volume was 2.98M shares, 1.1x its 50-day average of 2.69M.
- Price is -9.5% vs its 50-day average ($306.21) and -15.7% vs its 200-day average ($328.72).
- 52-week range $267.00–$392.55; today's close sits at 8% of that range, 29.4% below the 52-week high.
Oct 7, 2026 — SYK dips 1.0% to $275.40
- Closed at $275.40, -1.01% vs the prior close of $278.20. Day range $274.45–$281.96, opened at $280.16.
- Volume was 1.92M shares, 0.7x its 50-day average of 2.71M.
- Price is -10.5% vs its 50-day average ($307.72) and -16.3% vs its 200-day average ($329.11).
- 52-week range $267.00–$392.55; today's close sits at 7% of that range, 29.8% below the 52-week high.
Oct 6, 2026 — SYK dips 2.5% to $278.20
- Closed at $278.20, -2.46% vs the prior close of $285.22. Day range $277.10–$284.53, opened at $279.37.
- Volume was 2.86M shares, 1.1x its 50-day average of 2.69M.
- Price is -10.0% vs its 50-day average ($309.14) and -15.6% vs its 200-day average ($329.50).
- 52-week range $267.00–$392.55; today's close sits at 9% of that range, 29.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — SYK jumps 3.6% to $285.22
- Closed at $285.22, +3.55% vs the prior close of $275.43. Day range $275.00–$286.09, opened at $275.50.
- Volume was 3.33M shares, 1.2x its 50-day average of 2.67M.
- Price is -8.1% vs its 50-day average ($310.31) and -13.5% vs its 200-day average ($329.87).
- 52-week range $267.00–$392.55; today's close sits at 15% of that range, 27.3% below the 52-week high.
Oct 2, 2026 — SYK rises 0.9% to $275.43
- Closed at $275.43, +0.90% vs the prior close of $272.96. Day range $271.21–$276.97, opened at $273.19.
- Volume was 2.00M shares, 0.7x its 50-day average of 2.68M.
- Price is -11.5% vs its 50-day average ($311.21) and -16.6% vs its 200-day average ($330.20).
- 52-week range $267.00–$392.55; today's close sits at 7% of that range, 29.8% below the 52-week high.
SYK latest news & SEC filings
Every SEC filing by or about SYK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 28, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wells Preston Wendell reported an other transaction of 109 shares on Sep 24, 2026; now holds 3,661
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wells Preston Wendell reported an other transaction of 1,777 shares on Jul 17, 2026; now holds 4,732
- Wells Preston Wendell reported an other transaction of 962 shares on Sep 22, 2026; now holds 3,770
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Crotty Dylan Bram sold 441 shares at $328.61 (≈$144.92K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stryker Ronda E sold 2,308 shares at $337.98 (≈$780.06K) on Aug 19, 2026
- Stryker Ronda E sold 320 shares at $336.79 (≈$107.77K) on Aug 19, 2026
- Stryker Ronda E sold 10,812 shares at $339.71 (≈$3.67M) on Aug 19, 2026
- Stryker Ronda E sold 16,612 shares at $340.71 (≈$5.66M) on Aug 19, 2026
- Stryker Ronda E sold 3,274 shares at $341.84 (≈$1.12M) on Aug 19, 2026
- Stryker Ronda E sold 3,852 shares at $342.80 (≈$1.32M) on Aug 19, 2026
- …plus 14 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 31, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $6.59B (prior year $6.02B) (+9.4% vs Jun 30, 2025)
- Net income: $1.28B (prior year $884.00M) (+44.3% vs Jun 30, 2025)
- Diluted EPS: $3.30 (prior year $2.29) (+44.1% vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 26, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade SYK
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Jan 29, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.24% (largest 4.1%).
- Liquidity: about 2.59M shares (≈$758.56M) trade per day on average.
- 52-week position: $293.23 vs a range of $267.00–$392.55 (21% of the range).
- Dividends: last ex-dividend date Sep 30, 2026 ($0.88/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Dylan Bram Crotty sold 441 shares on Aug 21, 2026.
- Latest filings: 8-K Oct 6, 2026; 10-Q Jul 31, 2026; 8-K Jul 30, 2026.
- Share count: 383.57M shares outstanding (Jun 30, 2026), +0.3% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
SYK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 287.00 | 293.99 | 286.55 | 293.23 | 3.12M |
| Oct 14, 2026 | 285.66 | 285.66 | 278.58 | 281.62 | 2.23M |
| Oct 13, 2026 | 284.23 | 287.45 | 278.62 | 282.55 | 2.07M |
| Oct 12, 2026 | 277.30 | 283.65 | 274.50 | 282.60 | 1.81M |
| Oct 9, 2026 | 277.01 | 281.58 | 276.53 | 277.33 | 1.48M |
| Oct 8, 2026 | 275.72 | 277.97 | 271.67 | 276.97 | 2.98M |
| Oct 7, 2026 | 280.16 | 281.96 | 274.45 | 275.40 | 1.92M |
| Oct 6, 2026 | 279.37 | 284.53 | 277.10 | 278.20 | 2.86M |
| Oct 5, 2026 | 275.50 | 286.09 | 275.00 | 285.22 | 3.33M |
| Oct 2, 2026 | 273.19 | 276.97 | 271.21 | 275.43 | 2.00M |
| Oct 1, 2026 | 275.60 | 278.51 | 271.34 | 272.96 | 2.46M |
| Sep 30, 2026 | 276.26 | 279.37 | 273.05 | 275.39 | 2.93M |
| Sep 29, 2026 | 277.00 | 280.17 | 274.31 | 278.77 | 2.79M |
| Sep 28, 2026 | 273.50 | 276.94 | 271.10 | 275.31 | 2.49M |
| Sep 25, 2026 | 269.93 | 275.84 | 268.69 | 272.36 | 2.34M |
| Sep 24, 2026 | 273.22 | 275.71 | 269.73 | 269.75 | 2.29M |
| Sep 23, 2026 | 274.46 | 277.10 | 271.45 | 273.40 | 2.72M |
| Sep 22, 2026 | 277.00 | 278.99 | 274.99 | 275.09 | 2.36M |
| Sep 21, 2026 | 274.58 | 276.87 | 272.00 | 274.19 | 2.76M |
| Sep 18, 2026 | 278.02 | 279.26 | 274.37 | 275.12 | 4.80M |
About Stryker
Stryker (SYK) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in PORTAGE, MI. State of incorporation: MI. Fiscal year ends December 31. SEC CIK 310764.
SYK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mary K Brainerd | Director | Sep 2, 2026 |
| Giovanni Caforio | Director | May 8, 2026 |
| Kevin Lobo | Chair and CEO | Mar 24, 2026 |
| Emmanuel Perez Maceda | Director | May 8, 2026 |
| Sherilyn S Mccoy | Director | May 8, 2026 |
| Rachel Ruggeri | Director | May 8, 2026 |
| Ronda E Stryker | Director | Aug 20, 2026 |
| Andrew K Silvernail | Director | May 8, 2026 |
| Tatum Lisa M Skeete | Director | May 8, 2026 |
| Rajeev Suri | Director | May 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Emily Kay Baculik | VP, Corporate Controller | Sep 8, 2026 |
| William E Jr Berry | VP, Chief Accounting Officer | Mar 24, 2026 |
| Dylan Bram Crotty | Group President | Aug 26, 2026 |
| M Kathryn Fink | VP, Chief HR Officer | Aug 4, 2026 |
| Robert S Fletcher | VP, Chief Legal Officer | Aug 4, 2026 |
| Debra King | See Remarks | Aug 18, 2026 |
| Kevin Lobo | Chair and CEO | Mar 24, 2026 |
| Viju Menon | Group President | Mar 24, 2026 |
| Kimberly Ann Montagnino | VP, Chief Comm. Officer | Aug 4, 2026 |
| James Andrew Pierce | Group President | Mar 24, 2026 |
| Spencer S Stiles | President and COO | Jun 2, 2026 |
| Preston Wendell Wells | VP, Chief Financial Officer | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Dylan Bram Crotty | Sale | 441 | $328.61 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 2,308 | $337.98 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 320 | $336.79 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 10,812 | $339.71 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 16,612 | $340.71 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 3,274 | $341.84 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 3,852 | $342.80 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 805 | $343.47 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 40 | $331.81 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 440 | $333.18 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 200 | $333.93 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 80 | $335.06 |
| Aug 19, 2026 | Ronda E Stryker | Sale | 11,257 | $338.90 |
| Aug 18, 2026 | Ronda E Stryker | Sale | 25,536 | $334.95 |
| Aug 18, 2026 | Ronda E Stryker | Sale | 2,239 | $331.74 |
SYK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $25.12B | $3.25B | 8.40 | $5.04B |
| Dec 31, 2024 | $22.59B | $2.99B | 7.76 | $4.24B |
| Dec 31, 2023 | $20.50B | $3.17B | 8.25 | $3.71B |
| Dec 31, 2022 | $18.45B | $2.36B | 6.17 | $2.62B |
| Dec 31, 2021 | $17.11B | $1.99B | 5.21 | $3.26B |
Latest balance sheet: total assets $47.93B, total liabilities $23.94B, cash $3.39B (as of Jun 30, 2026).
SYK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $348.04 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $315.13 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $354.30 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $368.98 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $392.73 |
| May 1, 2025 | 8-K Item 2.02 (results) | $373.99 |
| Jan 28, 2025 | 8-K Item 2.02 (results) | $395.15 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $359.01 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| Apr 30, 2024 | 8-K Item 2.02 (results) | — |
| Jan 30, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on SYK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.